Freenome, Inc.(FRNM)

Medical - Diagnostics & Research · Brisbane, CA

$16.98+0.15 (+0.86%)

Delayed quote: Oct 6, 2026, 10:10 AM EDT

EBITDA Yield: N/A

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T14:12:00.063Z.

Stored calculation inputs

Calculation as of: 2026-10-06T14:12:00.063Z.

Quote observation: 2026-10-06T14:10:01.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA: N/A
Quote market capitalization: 138,469,183
Total debt: N/A
Cash: N/A

FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

FRNM EBITDA Yield Metrics

EBITDA YIELD

N/A

FRNM Competitors' EBITDA Yield

FRNM

Freenome, Inc.

Current

Market Cap

$138.47M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KRMD

KORU Medical Systems, Inc.

vs FRNM

Market Cap

$137.57M

EBITDA Yield

N/A

TTM Avg

0.23%

3Y Avg

1.76%

5Y Avg

3.40%

ACOG

Alpha Cognition Inc

vs FRNM

Market Cap

$140.09M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AIRS

AirSculpt Technologies, Inc.

vs FRNM

Market Cap

$139.95M

EBITDA Yield

0.22%

TTM Avg

0.33%

3Y Avg

3.24%

5Y Avg

2.95%

LFMD

LifeMD, Inc.

vs FRNM

Market Cap

$135.83M

EBITDA Yield

N/A

TTM Avg

4.68%

3Y Avg

4.68%

5Y Avg

4.68%

FBIOP

Fortress Biotech, Inc.

vs FRNM

Market Cap

$141.70M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMRX

Immuneering Corporation

vs FRNM

Market Cap

$144.79M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HCAT

Health Catalyst, Inc.

vs FRNM

Market Cap

$131.16M

EBITDA Yield

1.34%

TTM Avg

1.37%

3Y Avg

1.37%

5Y Avg

1.37%

KRSA

Korsana Biosciences, Inc.

vs FRNM

Market Cap

$146.71M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ABOS

Acumen Pharmaceuticals, Inc.

vs FRNM

Market Cap

$148.07M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Freenome, Inc. (FRNM)	$138.47M	N/A	N/A	N/A	N/A
KORU Medical Systems, Inc. (KRMD)vs ›	$137.57M	N/A	0.23%	1.76%	3.40%
Alpha Cognition Inc (ACOG)vs ›	$140.09M	N/A	N/A	N/A	N/A
AirSculpt Technologies, Inc. (AIRS)vs ›	$139.95M	0.22%	0.33%	3.24%	2.95%
LifeMD, Inc. (LFMD)vs ›	$135.83M	N/A	4.68%	4.68%	4.68%
Fortress Biotech, Inc. (FBIOP)vs ›	$141.70M	N/A	N/A	N/A	N/A
Immuneering Corporation (IMRX)vs ›	$144.79M	N/A	N/A	N/A	N/A
Health Catalyst, Inc. (HCAT)vs ›	$131.16M	1.34%	1.37%	1.37%	1.37%
Korsana Biosciences, Inc. (KRSA)vs ›	$146.71M	N/A	N/A	N/A	N/A
Acumen Pharmaceuticals, Inc. (ABOS)vs ›	$148.07M	N/A	N/A	N/A	N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

FRNM EBITDA Yield Metrics

FRNM Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics